Feb 9 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – FDA GRANTS ADDITIONAL EXCLUSIVITY FOR ACCRUFER * SHIELD THERAPEUTICS : EXCLUSIVITY REMAINS IN PLACE UNTIL 19 DEC 2028 IN ADDITION TO ACCRUFER/FERACCRU PATENT COVERAGE VALID UNTIL MID-2030S Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
New Delhi [India], April 01: K Malhotra, a foremost architect of India’s hydropower and Irrigation…
New Delhi [India], April 02: In a defining moment for India’s AI revolution, Sanjay Gondaliya,…
New Delhi [India], April 02: The latest episode of MK Talks, hosted by Mohsin Khan,…
New Delhi [India], March 31: We are proud to share that Jotwani Associates has been…
Surat (Gujarat) [India], April 01: Known as the Diamond and Textile City, Surat is now…
Mr. Devang Thakur, President, ECAM Mumbai (Maharashtra) [India], April 02: As India’s electrical industry accelerates…